CTVA vs AVD vs GNVR Stock Comparison

Corteva, American Vanguard and Genvor Prices as of Nov 13, 2026 Peers: Industry group
CTVA Corteva, Inc.
$9.43 -29.6% 1M -85.8% 1Y
Market cap
$6.10B
P/E
8.0x
Revenue (TTM)
$17.65B
Div. yield
–
Crop Protection and Seeds Basic Materials
6 wins
AVD American Vanguard Corp
$0.88 -22.8% 1M -82.7% 1Y
Market cap
$23.16M
P/E
–
Revenue (TTM)
$499.39M
Div. yield
–
Crop Protection and Seeds Basic Materials
3 wins
GNVR Genvor Inc
$0.75 -16.7% 1M -61.5% 1Y
Market cap
$27.31M
P/E
–
Revenue (TTM)
—
Div. yield
–
Crop Protection and Seeds Basic Materials
1 win

Head to Head

10 decided of 12

Corteva leads on 6 of the 12 questions below (Corteva 6, American Vanguard 3, Genvor 1). Which ones matter depends on what you are buying for; a cheap multiple and slow growth often come together.

QuestionCTVAAVDGNVRLeader
Larger companyMarket capitalisation $6.10B $23.16M $27.31M CTVA
Cheaper on earningsLower P/E, profitable companies only 8.0x -0.4x -7.8x –
Cheaper on forward earningsLower price / next fiscal year consensus EPS 15.5x 2.2x — AVD
Faster revenue growthRevenue growth, trailing twelve months +1.0% -5.8% — CTVA
More profitableNet margin, trailing twelve months 4.3% -12.0% — CTVA
Better return on capitalReturn on invested capital 7.1% -6.4% — CTVA
Less leveragedLower net debt / EBITDA 0.8x -28.7x — AVD
Higher dividend yieldTrailing dividend yield 0.00% 0.00% — –
Better 1-year returnPrice return, last 12 months -85.8% -82.7% -61.5% GNVR
Better 5-year returnAnnualised price return, 5 years -28.0%/yr -44.9%/yr — CTVA
Less volatileAnnualised volatility, 1 year 187.9% 72.7% 280.2% AVD
Higher overall scoreMean of the five percentile scores vs peers 65/100 26/100 14/100 CTVA

Percentile Scorecard

CTVAAVDGNVR

Each axis is the mean percentile of its metrics against the company's industry group. 100 is the best in the group, 50 the middle.

Scores by Axis

AxisCTVAAVDGNVR
Valuation 98 #3 of 96 36 #62 of 96 12 #85 of 96
Growth 42 #54 of 92 23 #71 of 92 28 #67 of 92
Profitability 53 #42 of 89 28 #64 of 89 –
Financial Health 58 #41 of 96 26 #71 of 96 1 #95 of 96
Shareholder Returns 72 #23 of 79 18 #65 of 79 17 #66 of 79
Overall 65 26 14
  • CTVA ranked among 99 companies in Chemicals
  • AVD ranked among 99 companies in Chemicals
  • GNVR ranked among 99 companies in Chemicals

Price Performance

Price return, split-adjusted, before dividends. Click a name to hide or show it.

Returns

PeriodCTVAAVDGNVRSPY
1 month -29.6%-22.8%-16.7% -2.0%
3 months -87.7%-58.5%+36.4% -2.8%
6 months -88.5%-68.0%+50.0% +2.0%
Year to date -85.9%-77.0%-25.0% +10.6%
1 year -85.8%-82.7%-61.5% +12.2%
3 years -79.6%-90.4%— +68.1%
3 years, per year -41.2%-54.2%— +18.9%
5 years -80.6%-94.9%— +61.4%
5 years, per year -28.0%-44.9%— +10.1%
10 years —-94.5%— +248.5%
10 years, per year —-25.2%— +13.3%

Risk

MeasureCTVAAVDGNVRSPY
Volatility, 1Y 187.9%72.7%280.2% 13.6%
Downside volatility, 1Y 275.9%83.7%465.6% 13.9%
Beta vs S&P 500, 1Y -0.010.84-0.56 1.00
Return / volatility, 1Y -0.46-1.14-0.22 0.90
Max drawdown, 5Y -89.8%-96.8%-97.5% -25.4%
From 52-week high -89.6%-83.7%-62.5% -3.2%
52-week high $90.53$5.41$2.00 $779.14
52-week low $9.19$0.82$0.20 $631.97

Valuation History

Weekly multiples on trailing twelve-month fundamentals. Negative or extreme readings (a loss year, a collapsed denominator) are left out so the chart stays readable.

MultipleCTVAAVDGNVR
P/E now vs peer median 8.3xmedian 23.4x -0.4xmedian 23.4x -7.8xmedian 23.4x
P/S now vs peer median 0.4xmedian 1.3x 0.1xmedian 1.3x —median 1.3x
EV/EBITDA now vs peer median 2.1xmedian 12.7x -32.7xmedian 12.7x —median 12.7x
P/FCF now vs peer median 10.3xmedian 17.0x -2.1xmedian 17.0x -25.9xmedian 17.0x
P/B now vs peer median 0.3xmedian 1.5x 0.2xmedian 1.5x -10.1xmedian 1.5x
PEG now vs peer median -1.69median 1.72 0.00median 1.72 0.73median 1.72

Financial History

Reported figures by fiscal period, placed on the calendar year (or quarter) each period ended in, so companies with different fiscal years line up.

Trailing twelve monthsCTVAAVDGNVR
Revenue $17.65B $499.39M –
Gross profit $8.77B $141.99M –
Operating income $3.43B -$28.23M -$4.01M
Net income $771.00M -$59.89M -$3.45M
Free cash flow $610.00M -$12.59M -$1.05M
R&D $1.54B $23.12M $386.20K
EPS (diluted) $1.13 $-2.08 $-0.10
Cash & equivalents $3.93B $83.91M $196.52K
Total debt $7.45B $267.69M $365.94K
Shares (diluted) 670.70M 28.78M 36.08M
Enterprise value -$6.69B -$187.99M $26.88M

All Metrics

58 metrics · best in bold

Bold marks the best reading: the lowest positive value for multiples, leverage and payout, the highest for everything else. The bar under each value is its percentile against that company's own peers. Hover a value for its rank and the peer median.

Valuation

12 metrics
MetricCTVAAVDGNVR
P/E 8.3x -0.4x -7.8x
P/FCF 10.3x -2.1x -25.9x
P/Operating cash flow 13.2x -4.1x -25.9x
P/S 0.4x 0.1x –
P/B 0.3x 0.2x -10.1x
P/Tangible book 0.4x -0.2x -10.1x
EV/EBITDA 2.1x -32.7x –
EV/EBIT 2.9x -7.4x -6.9x
EV/Revenue 0.6x 0.4x –
EV/FCF 16.1x -16.7x -26.1x
EV/Operating cash flow 20.6x -32.8x -26.1x
PEG (3Y EPS CAGR) -1.69 0.00 0.73

Growth

14 metrics
MetricCTVAAVDGNVR
Revenue growth (1Y) 1.0% -5.8% –
Revenue CAGR (3Y) 0.6% -4.1% –
Gross profit growth (1Y) 8.9% 11.1% –
Gross profit CAGR (3Y) 6.4% -5.2% –
Operating income growth (1Y) 12.7% 63.1% 33.3%
Operating income CAGR (3Y) 9.7% -57.1% -55.6%
Net income growth (1Y) -52.3% 46.6% 41.0%
Net income CAGR (3Y) -6.6% -149.3% -38.4%
EPS growth (1Y) -52.1% 47.1% 55.1%
EPS CAGR (3Y) -4.9% -147.1% -10.7%
Operating cash flow growth (1Y) -85.8% -266.8% -151.3%
Operating cash flow CAGR (3Y) 1.7% 47.1% 1.7%
Free cash flow growth (1Y) -78.3% -136.9% -151.3%
Free cash flow CAGR (3Y) 99.4% 39.2% 1.7%

Profitability

14 metrics
MetricCTVAAVDGNVR
Gross margin 49.7% 28.4% –
EBITDA margin 26.5% -1.3% –
Operating margin 19.4% -5.7% –
Pretax margin 7.7% -11.6% –
Net margin 4.3% -12.0% –
FCF margin 3.5% -2.5% –
Operating cash flow margin 2.7% -1.3% –
Return on equity 3.1% -34.8% –
Return on assets 1.8% -9.2% -1,412%
Return on invested capital 7.1% -6.4% –
Return on capital employed 11.1% -6.5% –
Asset turnover 0.4x 0.8x –
Cash conversion (OCF / net income) 0.6x 0.1x 0.3x
Stock comp / revenue – 0.2% –

Financial Health

11 metrics
MetricCTVAAVDGNVR
Debt / assets 17.3% 40.4% 117.2%
Debt / equity 0.3x 1.6x -0.1x
Net debt / EBITDA 0.8x -28.7x –
Debt / FCF 12.2x -21.3x -0.3x
Liabilities / assets 43.1% 75.4% 969.3%
Equity / assets 56.9% 24.6% -869.3%
Interest coverage 16.8x -1.0x -37.1x
Current ratio 1.6x 2.0x 0.1x
Quick ratio 1.0x 1.1x 0.1x
Cash ratio 0.3x 0.4x 0.1x
Altman Z-score 1.07 1.30 –

Shareholder Returns

7 metrics
MetricCTVAAVDGNVR
Dividend yield 7.6% – –
Net buyback yield -4.0% -1.8% -2.8%
Shareholder yield 3.7% -1.8% -2.8%
Payout ratio (earnings) – – –
Payout ratio (FCF) – – –
Dividend growth (1Y) – – –
Dividend CAGR (3Y) – – –

Analyst Estimates

Solid lines are reported fiscal-year results; dashed lines are the consensus for the years ahead. Hover a year for the analysts' high and low, and how each result compared with its estimate.

ConsensusCTVAAVDGNVR
Forward P/E 15.5xFY2026 2.2xFY2026 –
EPS, next fiscal year $0.61FY2026 $0.40FY2026 –
EPS growth, next FY +22.0%FY2026 – –
EPS growth, the year after +14.8% +247.5% –
Revenue, next fiscal year $16.22BFY2026 $540.99MFY2026 –
Revenue growth, next FY -6.8%FY2026 +5.0%FY2026 –
Revenue growth, the year after -51.9% +0.9% –

Institutional Ownership

13F filings, quarter ended Jun 30, 2026
HoldersCTVAAVDGNVR
Held by institutions 88.8% 50.0% –
Institutions holding 1,483 107 –
Change in shares held, QoQ +2.9% -16.3% –
Institutions buying 649 57 –
Institutions selling 527 35 –
Buyers to sellers 1.23 1.63 –

Return Correlation

Daily returns, last 12 months

1.00 means two stocks move in lockstep, 0 that they move independently. Pairs below about 0.5 diversify each other.

CTVAAVDGNVR
CTVA 1.00 -0.01 0.01
AVD -0.01 1.00 -0.08
GNVR 0.01 -0.08 1.00

Add a Peer

Largest companies in the same industry

Related Comparisons

Frequently Asked Questions

Which is bigger, CTVA, AVD and GNVR?

Corteva (CTVA) is the largest by market capitalisation: Corteva (CTVA) $6.10B, American Vanguard (AVD) $23.16M, Genvor (GNVR) $27.31M.

Which company is growing faster?

Corteva (CTVA) grew revenue fastest over the trailing twelve months: Corteva (CTVA) +1.0%, American Vanguard (AVD) -5.8%.

Which company is more profitable?

Corteva (CTVA) has the highest net margin (Corteva (CTVA) 4.3%, American Vanguard (AVD) -12.0%). On return on invested capital, Corteva (CTVA) leads (Corteva (CTVA) 7.1%, American Vanguard (AVD) -6.4%).

Which stock has performed better?

Over the past year Genvor (GNVR) returned the most: Corteva (CTVA) -85.8%, American Vanguard (AVD) -82.7%, Genvor (GNVR) -61.5%. Over five years, Corteva (CTVA) compounded fastest (Corteva (CTVA) -28.0%/yr, American Vanguard (AVD) -44.9%/yr). Returns are price only, before dividends.

Which stock is riskier?

By one-year price volatility, American Vanguard (AVD) has been the steadiest (Corteva (CTVA) 187.9%, American Vanguard (AVD) 72.7%, Genvor (GNVR) 280.2%). Volatility measures how widely the price swings, not the risk of the business.

Which is the better stock, CTVA, AVD and GNVR?

There is no single answer; it depends on what you are buying for. On the 12 head-to-head measures on this page, Corteva (CTVA) leads on 6. Business Quant does not give investment advice; use the comparison as a starting point for your own research.

Data from SEC filings, exchange prices and consensus estimates, via Business Quant. Percentile scores compare each company with its own peer group, so two companies' scores are each relative to different peers unless you rank against the whole market. Price returns exclude dividends. Nothing on this page is investment advice.